Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100
The PD-L1 inhibitor Bavencio, when given as maintenance therapy to gastric cancer patients in a trial, was not superior to chemotherapy, but... Read More
Drug-Drug Interactions to Avoid in Patients With GI Cancer
People with HER2-positive gastric cancer should not take proton pump inhibitors for heartburn while they are undergoing treatment, recent studies have found.
Scientific American: What We Know about the Possible Carcinogen Found in Zantac
Concerned by the news that the widely used heartburn medication Zantac (ranitidine) was recalled due to a finding of a cancer-causing chemical?... Read More
Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis
A recent study of users of proton pump inhibitors to treat heartburn found that use of the drugs for 36 months or... Read More
